Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +24.17%
#4 Velvet Velvet +20.00%
#5 Bedrock Bedrock +18.02%
#6 Nockchain Nockchain +15.67%
#7 Fabric Protocol Fabric Protocol +14.55%
#8 Nillion Nillion +13.82%
#9 Perle Perle +13.30%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Classificação em ações #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Preço da ação
$0.07
Última sincronização: 2024-11-12
Valor de mercado
$1.62M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Peak Bio, Inc. (PKBO)

Categoria

Healthcare
Histórico de preços das ações de Peak Bio, Inc. (PKBO)
Preço de fecho mais alto: $0.07 em 2024-11-01

Preço de fecho mais baixo: $9.71 em 2021-03-01
Histórico de preços das ações da Peak Bio, Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 -26.66%
2023 -98.23%
2022 -44.81%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE